Amyloid Oligomers Exacerbate Tau Pathology in a Mouse Model of Tauopathy

Cited by (1,639)

Items 301–400 of 1,639

1. The Locus Coeruleus: Essential for Maintaining Cognitive Function and the Aging Brain
   Mara Mather, Carolyn W. Harley · 2016 · Trends in Cognitive Sciences
2. Role of toll-like receptor signalling in A uptake and clearance
   Tahara, K., Kim, H.-D., Jin, J.-J., Maxwell, J. A., Li, L., Fukuchi, K.-i. · 2006 · Brain
3. A Unifying Role for Prions in Neurodegenerative Diseases
   Stanley B. Prusiner · 2012 · Science
4. Breaking immune tolerance by targeting Foxp3+ regulatory T cells mitigates Alzheimer’s disease pathology
   Baruch, Kuti, Rosenzweig, Neta, Kertser, Alexander, Deczkowska, Aleksandra, Sharif, Alaa Mohammad, Spinrad, Amit, Tsitsou-Kampeli, Afroditi, Sarel, Ayelet, Cahalon, Liora, Schwartz, Michal · 2015 · Nature Communications
5. Microglial activation and tau propagate jointly across Braak stages
   Pascoal, Tharick A., Benedet, Andrea L., Ashton, Nicholas J., Kang, Min Su, Therriault, Joseph, Chamoun, Mira, Savard, Melissa, Lussier, Firoza Z., Tissot, Cécile, Karikari, Thomas K. et al. · 2021 · Nature Medicine
6. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging
   Terman, Alexei, Kurz, Tino, Navratil, Marian, Arriaga, Edgar A., Brunk, Ulf T. · 2010 · Antioxidants & Redox Signaling
7. The NLRP3 and NLRP1 inflammasomes are activated in Alzheimer’s disease
   Saresella, Marina, La Rosa, Francesca, Piancone, Federica, Zoppis, Martina, Marventano, Ivana, Calabrese, Elena, Rainone, Veronica, Nemni, Raffaello, Mancuso, Roberta, Clerici, Mario · 2016 · Molecular Neurodegeneration
8. Reduced IGF-1 signaling delays age-associated proteotoxicity in mice
   Cohen, Ehud, Paulsson, Johan F., Blinder, Pablo, Burstyn-Cohen, Tal, Du, Deguo, Estepa, Gabriela, Adame, Anthony, Pham, Hang M., Holzenberger, Martin, Kelly, Jeffery W. et al. · 2009 · Cell
9. Insulin Receptor Substrate-2 Deficiency Impairs Brain Growth and Promotes Tau Phosphorylation
   Schubert, Markus, Brazil, Derek P., Burks, Deborah J., Kushner, Jake A., Ye, Jing, Flint, Carrie L., Farhang-Fallah, Janet, Dikkes, Pieter, Warot, Xavier M., Rio, Carlos et al. · 2003 · The Journal of Neuroscience
10. Microglial Activation in Traumatic Brain Injury
    Cornelius Kurt Donat, Gregory Scott, Steve Gentleman, Magdalena Sastre · 2017 · Frontiers in Aging Neuroscience
11. Molecular characterization of selectively vulnerable neurons in Alzheimer’s disease
    Leng, Kun, Li, Emmy, Eser, Rana, Piergies, Antonia, Sit, Rene, Tan, Michelle, Neff, Norma, Li, Song Hua, Rodriguez, Roberta Diehl, Suemoto, Claudia Kimie et al. · 2021 · Nature Neuroscience
12. The presenilin hypothesis of Alzheimer’s disease: Evidence for a loss-of-function pathogenic mechanism.
    Shen, Jie, Kelleher, Raymond J. · 2007 · Proceedings of the National Academy of Sciences
13. Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy
    Zdenek Berger, Hanno M. Roder, Amanda Hanna, Aaron M. Carlson, Vijayaraghavan Rangachari, Mei Yue, Zbigniew K. Wszołek, Karen H. Ashe, Joshua A. Knight, Dennis W. Dickson et al. · 2007 · Journal of Neuroscience
14. CD36 Mediates the Innate Host Response to β-Amyloid
    El Khoury, Joseph B., Moore, Kathryn J., Means, Terry K., Leung, Josephine, Terada, Kinya, Toft, Michelle, Freeman, Mason W., Luster, Andrew D. · 2003 · The Journal of Experimental Medicine
15. Inflammatory Mechanisms in Alzheimer's Disease: Inhibition of β-Amyloid-Stimulated Proinflammatory Responses and Neurotoxicity by PPARγ Agonists
    Combs, Colin K., Johnson, Derrick E., Karlo, J. Colleen, Cannady, Steven B., Landreth, Gary E. · 2000 · The Journal of Neuroscience
16. Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila : A potential model for Alzheimer's disease
    Iijima, Koichi, Liu, Hsin-Ping, Chiang, Ann-Shyn, Hearn, Stephen A., Konsolaki, Mary, Zhong, Yi · 2004 · Proceedings of the National Academy of Sciences
17. Microglia and Astrocytes in Alzheimer's Disease: Implications for Therapy
    Marc Fakhoury · 2017 · Current Neuropharmacology
18. The Role of PI3K/Akt and ERK in Neurodegenerative Disorders
    Sachchida Nand, Hagera Dilnashin, Hareram Birla, Saumitra Sen Singh, Walia Zahra, Brijesh Kumar Singh, Surya Pratap Singh, Surya Pratap Singh · 2019 · Neurotoxicity Research
19. Phenylalanine assembly into toxic fibrils suggests amyloid etiology in phenylketonuria
    Lihi Adler‐Abramovich, Lilach Vaks, Ohad Carny, Dorit Trudler, Andrea Magno, Amedeo Caflisch, Dan Frenkel, Ehud Gazit · 2012 · Nature Chemical Biology
20. Microglial Phagocytosis Induced by Fibrillar β-Amyloid and IgGs Are Differentially Regulated by Proinflammatory Cytokines
    Koenigsknecht-Talboo, Jessica, Landreth, Gary E. · 2005 · The Journal of Neuroscience
21. Natural Dietary Supplementation of Anthocyanins via PI3K/Akt/Nrf2/HO-1 Pathways Mitigate Oxidative Stress, Neurodegeneration, and Memory Impairment in a Mouse Model of Alzheimer’s Disease
    Tahir Ali, Tae Hyun Kim, Shafiq Ur Rehman, Muhammad Sohail Khan, Faiz Ul Amin, Mehtab Khan, Muhammad Aimen Ikram, Myeong Ok Kim · 2017 · Molecular Neurobiology
22. Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17.
    Lorraine N. Clark, P. Poorkaj, Z. Wszolek, D. Geschwind, Ziad S. Nasreddine, Bruce L. Miller, Diane Li, H. Payami, Fre Awert, K. Markopoulou et al. · 1998 · Proceedings of the National Academy of Sciences of the United States of America
23. Excitotoxic and Excitoprotective Mechanisms: Abundant Targets for the Prevention and Treatment of Neurodegenerative Disorders
    Mark P. Mattson · 2003 · NeuroMolecular Medicine
24. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: implications for Alzheimer disease.
    Strittmatter, W J, Saunders, A M, Goedert, M, Weisgraber, K H, Dong, L M, Jakes, R, Huang, D Y, Pericak-Vance, M, Schmechel, D, Roses, A D · 1994 · Proceedings of the National Academy of Sciences
25. -Amyloid Oligomers Induce Phosphorylation of Tau and Inactivation of Insulin Receptor Substrate via c-Jun N-Terminal Kinase Signaling: Suppression by Omega-3 Fatty Acids and Curcumin
    Ma, Q.-L., Yang, F., Rosario, E. R., Ubeda, O. J., Beech, W., Gant, D. J., Chen, P. P., Hudspeth, B., Chen, C., Zhao, Y. et al. · 2009 · Journal of Neuroscience
26. NAD + supplementation normalizes key Alzheimer’s features and DNA damage responses in a new AD mouse model with introduced DNA repair deficiency
    Hou, Yujun, Lautrup, Sofie, Cordonnier, Stephanie, Wang, Yue, Croteau, Deborah L., Zavala, Eduardo, Zhang, Yongqing, Moritoh, Kanako, O’Connell, Jennifer F., Baptiste, Beverly A. et al. · 2018 · Proceedings of the National Academy of Sciences
27. TAR DNA-binding protein 43 in neurodegenerative disease
    Alice S. Chen‐Plotkin, Virginia M.‐Y. Lee, John Q. Trojanowski · 2010 · Nature Reviews Neurology
28. A novel in vivo model of tau propagation with rapid and progressive neurofibrillary tangle pathology: the pattern of spread is determined by connectivity, not proximity
    Zeshan Ahmed, Jane Cooper, Tracey K. Murray, Katya Garn, Emily McNaughton, Hannah Clarke, Samira Parhizkar, Mark A. Ward, Annalisa Cavallini, Samuel Jackson et al. · 2014 · Acta Neuropathologica
29. The role of microglia in retinal neurodegeneration: Alzheimer’s disease, parkinson, and glaucoma.
    Ramirez, Ana I., de Hoz, Rosa, Salobrar-Garcia, Elena, Salazar, Juan J., Rojas, Blanca, Ajoy, Daniel, López-Cuenca, Inés, Rojas, Pilar, Triviño, Alberto, Ramírez, José M. · 2017 · Frontiers in Aging Neuroscience
30. Axonal Transport Defects in Neurodegenerative Diseases
    Gerardo A. Morfini, Matthew R. Burns, Lester I. Binder, Nicholas M. Kanaan, Nichole E. LaPointe, Daryl A. Bosco, Robert H. Brown, Hannah E. Brown, Ashutosh Tiwari, Lawrence J. Hayward et al. · 2009 · Journal of Neuroscience
31. Chaperones increase association of tau protein with microtubules
    Fei Dou, William J. Netzer, Kentaro Tanemura, Feng Li, F. Ulrich Hartl, Akihiko Takashima, Gunnar K. Gouras, Paul Greengard, Huaxi Xu · 2003 · Proceedings of the National Academy of Sciences
32. Tau Protein Disrupts Nucleocytoplasmic Transport in Alzheimer’s Disease
    Eftekharzadeh, Bahareh, Daigle, J. Gavin, Kapinos, Larisa E., Coyne, Alyssa, Schiantarelli, Julia, Carlomagno, Yari, Cook, Casey, Miller, Sean J., Dujardin, Simon, Amaral, Ana S. et al. · 2018 · Neuron
33. Neuropathological background of phenotypical variability in frontotemporal dementia
    Keith A. Josephs, John R. Hodges, Julie S. Snowden, Ian R. Mackenzie, Manuela Neumann, David M. A. Mann, Dennis W. Dickson · 2011 · Acta Neuropathologica
34. Smoking and increased Alzheimer's disease risk: A review of potential mechanisms
    Timothy C. Durazzo, Niklas Mattsson, Michael Walter Weiner, Alzheimer’s Disease Neuroimaging Initiative · 2014 · Alzheimer s & Dementia
35. Bidirectional Microglia–Neuron Communication in Health and Disease
    Szepesi, Zsuzsanna, Manouchehrian, Oscar, Bachiller, Sara, Deierborg, Tomas · 2018 · Frontiers in Cellular Neuroscience
36. Disrupting the blood–brain barrier by focused ultrasound induces sterile inflammation
    Kovacs, Zsofia I., Kim, Saejeong, Jikaria, Neekita, Qureshi, Farhan, Milo, Blerta, Lewis, Bobbi K., Bresler, Michele, Burks, Scott R., Frank, Joseph A. · 2017 · Proceedings of the National Academy of Sciences
37. Novel Mutations in TARDBP (TDP-43) in Patients with Familial Amyotrophic Lateral Sclerosis
    Nicola J. Rutherford, Yong‐Jie Zhang, Matt C. Baker, Jennifer M. Gass, NiCole A. Finch, Yafei Xu, Heather G. Stewart, Brendan J. Kelley, Karen Kuntz, Richard Crook et al. · 2008 · PLoS Genetics
38. The Neural RNA-Binding Protein Musashi1 Translationally Regulates Mammalian numb Gene Expression by Interacting with Its mRNA
    Takao Imai, Akinori Tokunaga, Tetsu Yoshida, Mitsuhiro Hashimoto, Katsuhiko Mikoshiba, Gerry Weinmaster, Masato Nakafuku, Hideyuki Okano · 2001 · Molecular and Cellular Biology
39. Regulated phosphorylation and dephosphorylation of tau protein: effects on microtubule interaction, intracellular trafficking and neurodegeneration
    Melvin L. Billingsley, Randall L. Kincaid · 1997 · Biochemical Journal
40. Association Between Elevated Brain Amyloid and Subsequent Cognitive Decline Among Cognitively Normal Persons
    Donohue, Michael C., Sperling, Reisa A., Petersen, Ronald, Sun, Chung-Kai, Weiner, Michael W., Aisen, Paul S., for the Alzheimer’s Disease Neuroimaging Initiative · 2017 · JAMA
41. ApoE4 Accelerates Early Seeding of Amyloid Pathology
    Liu, Chia-Chen, Zhao, Na, Fu, Yuan, Wang, Na, Linares, Cynthia, Tsai, Chih-Wei, Bu, Guojun · 2017 · Neuron
42. Excitotoxicity, calcium and mitochondria: a triad in synaptic neurodegeneration
    Verma, Manish, Lizama, Britney N., Chu, Charleen T. · 2022 · Translational Neurodegeneration
43. Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases
    Jucker, Mathias, Walker, Lary C. · 2018 · Nature Neuroscience
44. Tau prion strains dictate patterns of cell pathology, progression rate, and regional vulnerability in vivo
    Kaufman, Sarah K., Sanders, David W., Thomas, Talitha L., Ruchinskas, Allison J., Vaquer-Alicea, Jaime, Sharma, Apurwa M., Miller, Timothy M., Diamond, Marc I. · 2016 · Neuron
45. Practical considerations for choosing a mouse model of Alzheimer’s disease
    Jankowsky, Joanna L., Zheng, Hui · 2017 · Molecular Neurodegeneration
46. Aggregated Tau activates NLRP3–ASC inflammasome exacerbating exogenously seeded and non-exogenously seeded Tau pathology in vivo
    Stancu, Ilie-Cosmin, Cremers, Niels, Vanrusselt, Hannah, Couturier, Julien, Vanoosthuyse, Alexandre, Kessels, Sofie, Lodder, Chritica, Brône, Bert, Huaux, François, Octave, Jean-Noël et al. · 2019 · Acta Neuropathologica
47. Microglial Phagocytosis of Fibrillar β-Amyloid through a β1Integrin-Dependent Mechanism
    Jessica Koenigsknecht-Talboo, Gary E. Landreth · 2004 · Journal of Neuroscience
48. Origin of microglia: current concepts and past controversies
    Ginhoux, Florent, Prinz, Marco · 2015 · Cold Spring Harbor Perspectives in Biology
49. Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling
    Myeku, Natura, Clelland, Catherine L, Emrani, Sheina, Kukushkin, Nikolay V, Yu, Wai Haung, Goldberg, Alfred L, Duff, Karen E · 2016 · Nature Medicine
50. Oligomerization of Alzheimer's β-Amyloid within Processes and Synapses of Cultured Neurons and Brain
    Takahashi, Reisuke H., Almeida, Claudia G., Kearney, Patrick F., Yu, Fangmin, Lin, Michael T., Milner, Teresa A., Gouras, Gunnar K. · 2004 · The Journal of Neuroscience
51. Alzheimer disease models and human neuropathology: similarities and differences
    Duyckaerts, Charles, Potier, Marie-Claude, Delatour, Benoît · 2008 · Acta Neuropathologica
52. White matter and cognition: making the connection
    Christopher Mark Filley, R. Douglas Fields · 2016 · Journal of Neurophysiology
53. Molecular and functional neuroscience in immunity
    Pavlov, Valentin A., Chavan, Sangeeta S., Tracey, Kevin J. · 2018 · Annual Review of Immunology
54. Amyloid Polymorphism: Structural Basis and Neurobiological Relevance
    Robert Tycko · 2015 · Neuron
55. Aberrant Expression of Mitotic Cdc2/Cyclin B1 Kinase in Degenerating Neurons of Alzheimer’s Disease Brain
    Inez J. Vincent, Gregory A. Jicha, Michelle Rosado, Dennis W. Dickson · 1997 · Journal of Neuroscience
56. The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer’s disease
    Ferreira, Sergio T., Klein, William L. · 2011 · Neurobiology of Learning and Memory
57. The multiplex model of the genetics of Alzheimer's disease
    Sims, Rebecca, Hill, Matthew, Williams, Julie · 2020 · Nature Neuroscience
58. Somatodendritic localization and hyperphosphorylation of tau protein in transgenic mice expressing the longest human brain tau isoform.
    Jürgen Götz, A. Probst, Maria Grazia Spillantini, Thomas Schäfer, Ross Jakes, Kurt Bürki, Michel Goedert · 1995 · The EMBO Journal
59. Unique pathological tau conformers from Alzheimer’s brains transmit tau pathology in nontransgenic mice
    Guo, Jing L., Narasimhan, Sneha, Changolkar, Lakshmi, He, Zhuohao, Stieber, Anna, Zhang, Bin, Gathagan, Ronald J., Iba, Michiyo, McBride, Jennifer D., Trojanowski, John Q. et al. · 2016 · Journal of Experimental Medicine
60. Microglial Function Is Distinct in Different Anatomical Locations during Retinal Homeostasis and Degeneration
    O’Koren, Emily G., Yu, Chen, Klingeborn, Mikael, Wong, Alicia Y.W., Prigge, Cameron L., Mathew, Rose, Kalnitsky, Joan, Msallam, Rasha A., Silvin, Aymeric, Kay, Jeremy N. et al. · 2019 · Immunity
61. Invited review: Frontotemporal dementia caused by microtubule‐associated protein tau gene ( MAPT ) mutations: a chameleon for neuropathology and neuroimaging
    Bernardino Francesco Ghetti, Adrian L. Oblak, Bradley F. Boeve, Keith A. Johnson, Bradford Clark Dickerson, Michel Goedert · 2014 · Neuropathology and Applied Neurobiology
62. Targeted Complement Inhibition at Synapses Prevents Microglial Synaptic Engulfment and Synapse Loss in Demyelinating Disease
    Werneburg, Sebastian, Jung, Jonathan, Kunjamma, Rejani B., Ha, Seung-Kwon, Luciano, Nicholas J., Willis, Cory M., Gao, Guangping, Biscola, Natalia P., Havton, Leif.A., Crocker, Stephen J. et al. · 2020 · Immunity
63. The physiological roles of tau and Aβ: implications for Alzheimer’s disease pathology and therapeutics
    Kent, Sarah A., Spires-Jones, Tara L., Durrant, Claire S. · 2020 · Acta Neuropathologica
64. The Neuropharmacological Basis for the Use of Memantine in the Treatment of Alzheimer's Disease
    Michael A. Rogawski, Gary L. Wenk · 2003 · CNS Drug Reviews
65. Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using Metabolomics
    Trushina, Eugenia, Dutta, Tumpa, Persson, Xuan-Mai T., Mielke, Michelle M., Petersen, Ronald C. · 2013 · PLoS ONE
66. The P2X7 Receptor in Inflammatory Diseases: Angel or Demon?
    Savio, Luiz E. B., de Andrade Mello, Paola, da Silva, Cleide Gonçalves, Coutinho-Silva, Robson · 2018 · Frontiers in Pharmacology
67. Block of Long-Term Potentiation by Naturally Secreted and Synthetic Amyloid β-Peptide in Hippocampal Slices Is Mediated via Activation of the Kinases c-Jun N-Terminal Kinase, Cyclin-Dependent Kinase 5, and p38 Mitogen-Activated Protein Kinase as well as Metabotropic Glutamate Receptor Type 5
    Wang, Qinwen, Walsh, Dominic M., Rowan, Michael J., Selkoe, Dennis J., Anwyl, Roger · 2004 · The Journal of Neuroscience
68. TFEB and TFE3: Linking Lysosomes to Cellular Adaptation to Stress
    Raben, Nina, Puertollano, Rosa · 2016 · Annual Review of Cell and Developmental Biology
69. The role of astrocytes in amyloid production and Alzheimer's disease
    Georgia R. Frost, Yue‐Ming Li · 2017 · Open Biology
70. Traumatic Brain Injury and Risk of Neurodegenerative Disorder
    Benjamin L. Brett, Raquel C. Gardner, Jonathan P. Godbout, Kristen Dams-O’Connor, Christopher Dirk Keene · 2021 · Biological Psychiatry
71. Tau association with synaptic vesicles causes presynaptic dysfunction
    Zhou, Lujia, McInnes, Joseph, Wierda, Keimpe, Holt, Matthew, Herrmann, Abigail G., Jackson, Rosemary J., Wang, Yu-Chun, Swerts, Jef, Beyens, Jelle, Miskiewicz, Katarzyna et al. · 2017 · Nature Communications
72. Lecanemab, Aducanumab, and Gantenerumab — Binding Profiles to Different Forms of Amyloid-Beta Might Explain Efficacy and Side Effects in Clinical Trials for Alzheimer's Disease
    Linda Söderberg, Malin Johannesson, Patrik Nygren, Hanna Laudon, Fredrik Eriksson, Gunilla Osswald, Christer Möller, Lars Lannfelt · 2022 · Neurotherapeutics
73. Reversing EphB2 depletion rescues cognitive functions in Alzheimer model
    Cissé, Moustapha, Halabisky, Brian, Harris, Julie, Devidze, Nino, Dubal, Dena B., Sun, Binggui, Orr, Anna, Lotz, Gregor, Kim, Daniel H., Hamto, Patricia et al. · 2011 · Nature
74. Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology
    Shaftel, Solomon S., Kyrkanides, Stephanos, Olschowka, John A., Miller, Jen-nie H., Johnson, Renee E., O’Banion, M. Kerry · 2007 · Journal of Clinical Investigation
75. Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental models
    Mafalda Cacciottolo, X Wang, Ira Frahmand Driscoll, N Woodward, Alexander Saffari, Jeanette M. Reyes, Marc L. Serre, William Vizuete, Constantinos Sioutas, Todd E. Morgan et al. · 2017 · Translational Psychiatry
76. The interplay of aging, genetics and environmental factors in the pathogenesis of Parkinson’s disease
    Shirley Yin-Yu Pang, Philip Wing‐Lok Ho, Huifang Liu, Chi-Ting Leung, Lingfei Li, Eunice Eun Seo Chang, David Boyer Ramsden, Shu‐Leong Ho · 2019 · Translational Neurodegeneration
77. Local cues establish and maintain region-specific phenotypes of basal ganglia microglia
    De Biase, Lindsay M., Schuebel, Kornel E., Fusfeld, Zachary H., Jair, Kamwing, Hawes, Isobel A., Cimbro, Raffaello, Zhang, Hai-Ying, Liu, Qing-Rong, Shen, Hui, Xi, Zheng-Xiong et al. · 2017 · Neuron
78. The mitochondria-targeted antioxidant MitoQ prevents loss of spatial memory retention and early neuropathology in a transgenic mouse model of Alzheimer’s disease
    McManus, Meagan J., Murphy, Michael P., Franklin, James L. · 2011 · The Journal of Neuroscience
79. Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer’s disease
    María Calvo-Rodríguez, Steven S. Hou, Austin C. Snyder, Elizabeth K. Kharitonova, Alyssa Russ, Sudeshna Das, Zhanyun Fan, Alona Muzikansky, Mónica Garcı́a-Alloza, Alberto Serrano‐Pozo et al. · 2020 · Nature Communications
80. Assessing Synaptic Density in Alzheimer Disease With Synaptic Vesicle Glycoprotein 2A Positron Emission Tomographic Imaging
    Chen, Ming-Kai, Mecca, Adam P., Naganawa, Mika, Finnema, Sjoerd J., Toyonaga, Takuya, Lin, Shu-fei, Najafzadeh, Soheila, Ropchan, Jim, Lu, Yihuan, McDonald, Julia W. et al. · 2018 · JAMA Neurology
81. Toll-like receptors in neurodegeneration
    Eitan Okun, Kathleen J. S. Griffioen, Justin Durla Lathia, Sung‐Chun Tang, Mark P. Mattson, Thiruma Valavan Arumugam · 2008 · Brain Research Reviews
82. Interactions of pathological proteins in neurodegenerative diseases
    Tara L. Spires‐Jones, Johannes Attems, Dietmar Rudolf Thal · 2017 · Acta Neuropathologica
83. Folding versus aggregation: Polypeptide conformations on competing pathways
    Thomas Robert Jahn, Sheena E. Radford · 2007 · Archives of Biochemistry and Biophysics
84. Balancing the immune response in the brain: IL-10 and its regulation
    Diogo Lobo‐Silva, Guilhermina M. Carriche, António G. Castro, Susana Roque, Margarida Saraiva · 2016 · Journal of Neuroinflammation
85. High Prevalence of Mutations in the Microtubule-Associated Protein Tau in a Population Study of Frontotemporal Dementia in the Netherlands
    Patrizia Rizzu, John Cornelis Van Swieten, Marijke Joosse, Masato Hasegawa, Martijn Stevens, Aad Tibben, Martinus F. Niermeijer, Marcel Hillebrand, Rivka Ravid, Ben A. Oostra et al. · 1999 · The American Journal of Human Genetics
86. Astrocyte contribution to dysfunction, risk and progression in neurodegenerative disorders
    Brandebura, Ashley N., Paumier, Adrien, Onur, Tarik S., Allen, Nicola J. · 2023 · Nature Reviews Neuroscience
87. Abnormal expression of the cell cycle regulators P16 and CDK4 in Alzheimer's disease.
    Andrew McShea, Peggy L.R. Harris, Kevin R. Webster, Alan F. Wahl, Mark A. Smith · 1997 · Europe PMC (PubMed Central)
88. Exosomes: new molecular targets of diseases
    Saheli Samanta, Sheeja Rajasingh, Nicholas Drosos, Zhigang Zhou, Buddhadeb Dawn, Johnson Rajasingh · 2017 · Acta Pharmacologica Sinica
89. MAPT mutations, tauopathy, and mechanisms of neurodegeneration
    Strang, Kevin H., Golde, Todd E., Giasson, Benoit I. · 2019 · Laboratory Investigation
90. The duality of the inflammatory response to traumatic brain injury
    McIntosh, Tracy K., Lenzlinger, Philipp M., Morganti-Kossmann, Maria-Cristina, Laurer, Helmut L. · 2001 · Molecular Neurobiology
91. Neuropathologic differentiation of progressive supranuclear palsy and corticobasal degeneration
    Dennis W. Dickson · 1999 · Journal of Neurology
92. Microglia and Inflammation in Alzheimers Disease
    Mandrekar-Colucci, Shweta, Landreth, Gary E. · 2010 · CNS & Neurological Disorders - Drug Targets
93. Astrocytes in Neurodegenerative Disease: Table 1.
    Phatnani, Hemali, Maniatis, Tom · 2015 · Cold Spring Harbor Perspectives in Biology
94. Drug candidates in clinical trials for Alzheimer’s disease
    Hung, Shih-Ya, Fu, Wen-Mei · 2017 · Journal of Biomedical Science
95. Targeting protein aggregation for the treatment of degenerative diseases
    Yvonne S. Eisele, Cecília Monteiro, Colleen Fearns, Sandra E. Encalada, R. Luke Wiseman, Evan T. Powers, Jeffery W. Kelly · 2015 · Nature Reviews Drug Discovery
96. Monocyte trafficking to the brain with stress and inflammation: a novel axis of immune-to-brain communication that influences mood and behavior
    Wohleb, Eric S., McKim, Daniel B., Sheridan, John F., Godbout, Jonathan P. · 2015 · Frontiers in Neuroscience
97. Molecular Pathogenesis of Alzheimer's Disease: An Update
    Alfredo Sanabria‐Castro, Ileana Alvarado Echeverría, Cecilia Monge Bonilla · 2017 · Annals of Neurosciences
98. Frontotemporal dementia
    Olney, Nicholas T., Spina, Salvatore, Miller, Bruce L. · 2017 · Neurologic Clinics
99. Near-atomic model of microtubule-tau interactions
    Kellogg, Elizabeth H., Hejab, Nisreen M. A., Poepsel, Simon, Downing, Kenneth H., DiMaio, Frank, Nogales, Eva · 2018 · Science
100. Locus coeruleus volume and cell population changes during Alzheimer's disease progression: A stereological study in human postmortem brains with potential implication for early‐stage biomarker discovery
     Theofilas, Panos, Ehrenberg, Alexander J., Dunlop, Sara, Di Lorenzo Alho, Ana T., Nguy, Austin, Leite, Renata Elaine Paraizo, Rodriguez, Roberta Diehl, Mejia, Maria B., Suemoto, Claudia K., Ferretti-Rebustini, Renata Eloah De Lucena et al. · 2017 · Alzheimer's & Dementia